Leaderboards/Hereditary Neurological Disorders

Hereditary Neurological Disorders

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Marie Goret
Centre National de la Recherche Scientifique
2
Lenka Súkeníková
ETH Zurich
3
Qinqin Cui
Zhejiang Lab
4
Julian E. Alecu
Boston Children's Hospital
5
Maurits F. J. M. Vissers
Centre for Human Drug Research
6
Daniel Zarhin
Tel Aviv Sourasky Medical Center
7
Burçak Özeş
Nationwide Children's Hospital
8
Jenica Acheta
Albany Medical Center Hospital
9
Yu-Tao Deng
Second Affiliated Hospital of Zhejiang University
10
Suzan Boutary
Inserm

Papers

1
Autoreactive T cells target peripheral nerves in Guillain–Barré syndrome
Nature|2024
55 cit.
2
Quantitative natural history modeling of HPDL-related disease based on cross-sectional data reveals genotype-phenotype correlations
Genetics in Medicine|2024
12 cit.
3
Publication in Nature Communications (2025) [8 citations, W4410521209]
Nature Communications|2025
8 cit.
4
Publication in Brain Communications (2024) [6 citations, W4404091268]
Brain Communications|2024
6 cit.
5
Therapeutic potential of siRNA PMP22-SQ nanoparticles for Charcot-Marie-Tooth 1A neuropathy in rodents and non-human primates
International Journal of Pharmaceutics|2025
6 cit.
6
Publication in Proceedings of the National Academy of Sciences (2025) [4 citations, W4408219014]
Proceedings of the National Academy of Sciences|2025
4 cit.
7
Publication in médecine/sciences (2024) [2 citations, W4392203125]
médecine/sciences|2024
2 cit.
8
NPT100-18A rescues mitochondrial oxidative stress and neuronal degeneration in human iPSC-based Parkinson’s model
BMC Neuroscience|2025
2 cit.
9
Low-intensity ultrasound stimulates TAZ in Schwann cells
Glial health research.|2025
0 cit.
10
Publication in bioRxiv (Cold Spring Harbor Laboratory) (2025) [W4417116790]
bioRxiv (Cold Spring Harbor Laboratory)|2025
0 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
S. S. Scherer
University of Toronto
2
Alexander M. Rossor
National Hospital for Neurology and Neurosurgery
3
Filip Eftimov
Amsterdam University Medical Centers
4
James Bilsland
Pfizer (United States)
5
Anja Nitzsche
Inserm
6
Aoibhinn McDonnell
Age UK
7
Lorena Riol‐Blanco
FX Palo Alto Laboratory
8
Dongmei Yu
China Tobacco
9
Yannick Poitelon
Albany Medical Center Hospital
10
Maurizio D’Antonio
IRCCS Ospedale San Raffaele

Papers

1
Piezo channels contribute to the regulation of myelination in Schwann cells
Glia|2022
86 cit.
2
Treatment with IFB-088 Improves Neuropathy in CMT1A and CMT1B Mice
Molecular Neurobiology|2022
42 cit.
3
Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy
Brain|2022
33 cit.
4
Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases
Annals of the Rheumatic Diseases|2022
23 cit.
5
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
Journal of Autoimmunity|2023
23 cit.
6
Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension study
Journal of Neurology Neurosurgery & Psychiatry|2024
23 cit.
7
Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial
Journal of the Peripheral Nervous System|2022
16 cit.
8
A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanism
Human Molecular Genetics|2022
12 cit.
9
Cc2d1b Contributes to the Regulation of Developmental Myelination in the Central Nervous System
Frontiers in Molecular Neuroscience|2022
9 cit.
10
B‐cell and T‐cell receptor repertoire in chronic inflammatory demyelinating polyneuropathy, a prospective cohort study
Journal of the Peripheral Nervous System|2023
6 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
James R. Lupski
Baylor College of Medicine
2
Klaus‐Armin Nave
Max Planck Institute of Experimental Medicine
3
Vincent Timmerman
University of Antwerp
4
Nobuhiro Yuki
Dokkyo University
5
Christine Van Broeckhoven
VIB-UAntwerp Center for Molecular Neurology
6
Ueli Suter
ETH Zurich
7
Mary M. Reilly
National Hospital for Neurology and Neurosurgery
8
Michael E. Shy
University of Iowa Health Care
9
Jeffery M. Vance
University of Miami
10
Hugh J. Willison
University of Glasgow

Papers

1
Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Science|1993
9.5k cit.
2
NanoPack: visualizing and processing long-read sequencing data
Bioinformatics|2018
3.3k cit.
3
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
Nature Genetics|1994
1.9k cit.
4
Genomic fingerprinting of bacteria using repetitive sequence-based polymerase chain reaction
Unknown Journal|1994
1.7k cit.
5
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
Nature Genetics|2004
1.6k cit.
6
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21
Nature|2006
1.5k cit.
7
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity
Nature|2012
1.5k cit.
8
DNA duplication associated with Charcot-Marie-Tooth disease type 1A
Cell|1991
1.3k cit.
9
Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination
Nature Genetics|2003
1k cit.
10
Axonal Neuregulin-1 Regulates Myelin Sheath Thickness
Science|2004
940 cit.

Reagents for Hereditary Neurological Disorders

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling Technology

Pim Kinase Antibody Sampler Kit

Cited in 5 papers
#9779$509
View Evidence →
Cell Signaling TechnologyEvidence 60

Alexa Fluor® 555 Phalloidin

#8953$502
View Evidence →
Sigma-Aldrich

Anti-Neurofilament 200 antibody produced in rabbit

#N4142
View Evidence →

🌟 All-Time

Most validated

R&D Systems

Human SOX10 Antibody

Cited in 6 papers
#AF2864 (also AF2864-SP)
View Evidence →
Cell Signaling Technology

Phospho-PDGF Receptor alpha (Tyr1018) Antibody

Cited in 5 papers
#4547$148,362
View Evidence →
Millipore

Anti-Peripherin

Cited in 5 papers
#AB1530
View Evidence →